Early Bird Savings End In
- 00Days
- 00Hrs
- 00Mins
- 00Secs
March 24, 2026 - ET (Eastern Time, GMT-05:00)
Kick off the day with fresh air and movement! Join industry colleagues for an invigorating Fun Run/Walk along Philadelphia’s scenic Riverwalk. Participants will meet in the Hilton Penn's Landing lobby at 6:00AM and cover about 2 miles. All abilities are welcome, whether you're a dedicated runner or prefer a leisurely walk.
- Stephen Rivera - Former Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson
Future-focused financial leadership
Talent development and retainment
Global market access and pricing – challenges, opportunities
Value creation beyond revenue
CPE Credits Available 1.2
In this powerful keynote session, attendees will experience a compelling perspective that transcends balance sheets and financial models—the authentic voice of patient advocacy. Our distinguished patient advocate speaker will share personal insights that illuminate the profound human impact behind every investment decision and financial strategy in life sciences.
CPE Credits Available 0.6
- T.J. Sharpe - Patient Engagement Expert, Sharpe Patient Insights
Current state of AI in accounting
Strategic implementation frameworks
Practical AI applications driving ROI
Competitive differentiation through AI
Ethical considerations and risk management
Future-proofing your organization
CPE Credits Available 1.0
- Prashanth Brindavan - Partner, Consulting, KPMG
This exclusive, closed-door roundtable brings together senior financial leaders from across the industry for a candid, peer-to-peer exchange on the challenges and opportunities shaping our sector. In this confidential environment, participants will engage in unfiltered discussions about the real-world implementation of cutting-edge financial strategies, technology adoption hurdles, and competitive positioning.
CPE Credits Available 1.8
- Stephen Rivera - Former Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson
- Kevin MacKay - Vice President, Global Technical Accounting Advisory Services & Policy, Pfizer
GTN fundamental frameworks
Strategic accrual methodologies
Government pricing calculations
GTN analytics and forecasting
GTN audit readiness and compliance
Case studies and modeling exercises
CPE Credits Available 1.8
Learn from transformative finance leaders and how they are harnessing data and advanced technologies through these key objectives:
Drive strategic decision-making and achieve organizational objectives using AI and other tech through real-life use cases
Streamline finance operations, including in FP&A and Controllership leveraging these technologies
Panelists will share practical examples on how they are addressing challenges and improving processes to enhance operations
CPE Credits Available 1.0
SOX compliance excellence
Tax frameworks
Data analytics
Creating value
IT compliance
Technology implementation to assist with documentation challenges
CPE Credits Available 1.0
- Robert Auslander - Vice President, Head of Internal Audit, Bausch & Lomb
- Anna Simansky - VP Global Audit Services, Zimmer Biomet
- Jessica Kahl-Winter - Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson
Current landscape for ERP solutions
What are the functionalities of most benefit?
What is missing?
Integration requirements
Compliance & legal
What data is most important to integrate
Automation opportunities
CPE Credits Available 1.0
- Stephen Sebastian - Executive Director, Corporate Controller, Immuneering Corporation
- Joseph Metzinger - Vice President, Chief Accounting Officer, Dynavax Technologies
How mid and large-size companies are leveraging AI and how to apply it to your organization
Accrual methodology development
Common pitfalls and error prevention
Audit readiness and documentation
Cross-functional collaboration models
Technology, AI and process solutions
CPE Credits Available 1.0
- Jennifer Kyle - Founder and CEO, Condor Software
Current political landscape impacting manufacturing
Financial implications of supply chain reconfiguration
Accounting for supply chain risk
Cost accounting
Compliance across global markets
Regulatory considerations
CPE Credits Available 1.0
- Trevor Ackerman - VP, Global Tax, Amneal Pharmaceuticals
- Sean Godbout - Global Corporate Controller, Biogen
A panel of senior business leaders will explore the evolving landscape of shared services, offering examples of improved efficiency, cost savings, and quality of implementation. Learnings will address:
Strategic benefits and challenges of implementation
Governance and change management
Leveraging technology and automation in delivery
CPE Credits Available 1.0
- Nick Cernese - Americas Healthcare & Life Sciences Finance Transformation Leader, Ernst & Young
IRA implementation lessons and real-world insights
Medicare Part D structural changes and financial implications
Manufacturer liability across coverage phases
IRA and gross-to-net interconnections
Most favored nation policy impact on drug pricing
340B program integration and compliance
Manufacturer financial impact analysis
Future considerations and strategic planning
CPE Credits Available 1.0
- Michael Buchanio - Managing Director | Deal Advisory & Strategy, KPMG
- Timothy Kocses - Executive Director, US Commercial Controller, Bristol Myers Squibb
This session offers university students and recent graduates a unique opportunity to engage directly with established leaders in life sciences accounting and finance. This interactive session bridges the gap between academic learning, the importance of having a designation in the profession for career sustainability and real-world application, providing invaluable insights for those preparing to enter this dynamic and rewarding field.
Topics include:
Career path discussions
Industry insights and trends
Skill development guidance and professional designations
CPE Credits Available 1.0
- Stephen Rivera - Former Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson
- George Botic (invited) - Board Member, Public Company Accounting Oversight Board
- Albert DeRitis - Assistant Clinical Professor, Accounting, Drexel University
- Kevin Nee - Vice President, Finance, Collegium
Valuation fundamentals for assets
Advanced methodologies for complex scenarios
Financial reporting valuation requirements
Complex collaboration agreements
Fair value considerations
Emerging challenges
CPE Credits Available 1.0
This exclusive, industry-only session creates a protected environment where financial leaders from small and emerging biotech companies can engage in candid, unfiltered discussions about their unique challenges and opportunities. Limited strictly to biotech company participants, this forum fosters authentic peer-to-peer exchange and collaborative problem-solving in a non-competitive atmosphere.
As smaller biotech organizations navigate complex financial landscapes with limited resources, this session provides a rare opportunity to share experiences, discuss sensitive topics, and develop practical solutions alongside peers who truly understand your specific constraints and pressures.
CPE Credits Available 1.0
- Christian Alaia - Senior Director, FP&A, Immuneering Corporation
Evolving role of finance
Strategy for innovation-driven organizations
Board and investor communication strategies
CPE Credits Available 1.0
This open forum allows senior-level executives to exchange ideas and best practices for driving internal and organizational success through efficiencies, technology and new innovations.
*Informa Connect reserves the right to qualify participants for this session. Attendees must be a Director/Senior Director/VP/C-Suite with 10+ years' experience and currently employed by a life sciences manufacturer.
CPE Credits Available 1.0